Where Will Pfizer Be in 5 Years?

Where Will Pfizer Be in 5 Years?

Source: 
Motley Fool
News Tags: 
snippet: 

Investors threw piles of money at up-and-coming biotechs last year, and that was before the coronavirus pandemic accelerated the trend even further. This capital isn't taking any direct routes to big pharmaceutical companies, but it's going to reverberate along Pfizer's (NYSE:PFE) bottom line eventually.

Over the next five years, investors can expect a lot more new drug approvals to emerge from Pfizer's pipeline than they're used to. Here why a recent frenzy for biotech start-ups makes Pfizer a good stock to buy now and hold for the long run.